317 related articles for article (PubMed ID: 10825465)
1. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
[TBL] [Abstract][Full Text] [Related]
2. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
[TBL] [Abstract][Full Text] [Related]
3. A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells.
De Haan LH; Boerboom AM; Rietjens IM; van Capelle D; De Ruijter AJ; Jaiswal AK; Aarts JM
Biochem Pharmacol; 2002 Dec; 64(11):1597-603. PubMed ID: 12429349
[TBL] [Abstract][Full Text] [Related]
4. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis.
Joseph P; Klein-Szanto AJ; Jaiswal AK
Br J Cancer; 1998 Aug; 78(3):312-20. PubMed ID: 9703276
[TBL] [Abstract][Full Text] [Related]
5. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Celli CM; Tran N; Knox R; Jaiswal AK
Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
[TBL] [Abstract][Full Text] [Related]
6. The role of quinone reductase (NQO1) and quinone chemistry in quercetin cytotoxicity.
Gliszczyńska-Swigło A; van der Woude H; de Haan L; Tyrakowska B; Aarts JM; Rietjens IM
Toxicol In Vitro; 2003 Aug; 17(4):423-31. PubMed ID: 12849725
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
Joseph P; Jaiswal AK
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
Joseph P; Jaiswal AK
Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.
Long DJ; Waikel RL; Wang XJ; Perlaky L; Roop DR; Jaiswal AK
Cancer Res; 2000 Nov; 60(21):5913-5. PubMed ID: 11085502
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress.
Nemeikaite-Ceniene A; Sarlauskas J; Anusevicius Z; Nivinskas H; Cenas N
Arch Biochem Biophys; 2003 Aug; 416(1):110-8. PubMed ID: 12859987
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity.
Radjendirane V; Joseph P; Lee YH; Kimura S; Klein-Szanto AJ; Gonzalez FJ; Jaiswal AK
J Biol Chem; 1998 Mar; 273(13):7382-9. PubMed ID: 9516435
[TBL] [Abstract][Full Text] [Related]
12. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
Powis G; See KL; Santone KS; Melder DC; Hodnett EM
Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
[TBL] [Abstract][Full Text] [Related]
13. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
Dehn DL; Winski SL; Ross D
Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
[TBL] [Abstract][Full Text] [Related]
14. NADPH-quinone oxidoreductase-1 mediates Benzo-[a]-pyrene-1,6-quinone-induced cytotoxicity and reactive oxygen species production in human EA.hy926 endothelial cells.
Shukla H; Gaje G; Koucheki A; Lee HY; Sun X; Trush MA; Zhu H; Li YR; Jia Z
Toxicol Appl Pharmacol; 2020 Oct; 404():115180. PubMed ID: 32739527
[TBL] [Abstract][Full Text] [Related]
15. A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C.
Joseph P; Jaiswal AK
Br J Cancer; 2000 Apr; 82(7):1305-11. PubMed ID: 10755406
[TBL] [Abstract][Full Text] [Related]
16. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
[TBL] [Abstract][Full Text] [Related]
17. In vivo relevance of two critical levels for NAD(P)H:quinone oxidoreductase (NQO1)-mediated cellular protection against electrophile toxicity found in vitro.
de Haan LH; Pot GK; Aarts JM; Rietjens IM; Alink GM
Toxicol In Vitro; 2006 Aug; 20(5):594-600. PubMed ID: 16314070
[TBL] [Abstract][Full Text] [Related]
18. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics.
Ross D; Siegel D
Methods Enzymol; 2004; 382():115-44. PubMed ID: 15047100
[No Abstract] [Full Text] [Related]
20. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
Rashid MH; Babu D; Siraki AG
Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
